https://orcid.org/0000-0003-1889-2855
References
- Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol 2019;15:137–52.
- Tanaka Y, Tummala R. Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials. Mod Rheumatol 2021;31:1–12.
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
- Hirohata S, Kanai Y, Mitsuo A, Tokano Y, Hashimoto H. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol 2009;28:1319–23.
- Miyachi K, Iwamoto T, Kojima S, Ida T, Suzuki J, Yamamoto T, et al. Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis. Arthritis Res Ther 2023;25:26.
- Hirose Y, Hashimoto K, Murase R, Yoshioka H, Wakai T, Tateoka T, et al. Subarachnoid hemorrhage because of ruptured multiple peripheral fusiform aneurysms associated with systemic lupus erythematosus: a case report. Neurosurg Pract Published online: 6 October 2023 doi:10.1227/neuprac.0000000000000064
- Aw E, Zhang Y, Carroll M. Microglial responses to peripheral type 1 interferon. J Neuroinflammation 2020;17:340.
- Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992;35:417–22.
- The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608.
- Oke V, Gunnarsson I, Dorschner J, Eketjäll S, Zickert A, Niewold TB, et al. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Res Ther 2019;21:107.
- Shirahama Y, Hashimoto A, Ono N, Takeyama Y, Maruyama A, Inoue T, et al. Relationships between type 1 IFN signatures and clinical features of the newly-onset lupus patients in Japan. Mod Rheumatol. Published online: 25 January 2023. doi:10.1093/mr/road015